Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors

Journal of NeuroVirology

Volumn 6, Issue 1, 2000, Pages 84-88

  Sacktor, Ned Charlton ^a   Skolasky, Richard L ^b   Lyles, Robert H ^c   Esposito, Doreen ^a   Selnes, Ola A ^a   McArthur, Justin C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Grooved pegboard; HIV; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAND FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTOR PERFORMANCE; NEUROPSYCHOLOGY; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034062389     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009006385     Document Type: Article

References (21)

1. Brodt HR, Kamps BS, Gute P, Knupp B, Staszevski S, Helm EB (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11: 1731-1738.
2. Centers for Disease Control (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36(Suppl. 15): 35-155.
3. Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607-613.
4. Collier A, Marra C, Coombs RW (1997). Cerebrospinal fluid (CSF) RNA levels in patients on chronic indinavir therapy (abstract 22). Abstracts of the Infectious Disease Society of America, 35th annual meeting, San Francisco Sept 13-16.
5. Concha M, Selnes OA, McArthur JC, Nancé-Sprson T, Updike ML, Royal W, III, Soloman L, Vlahov D (1995). Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict 30: 823-841.
6. Condra JH, Emini EA (1997). Preventing HIV-1 drug resistance. Sci Med 4: 14-23.
7. Ferrando S, Rabkin J, Van Gorp W, McElhiney M (1998). Protease inhibitors are associated with less neuropsychological impairment with HIV infection. 5th Conference on Retroviruses and Opportunistic Infections, Abstract 186, Chicago, IL, USA.
8. Hestad K, McArthur JH, Dal Pan GJ, Selnes OA, Nance-Sproson TE, Aylward E, Mathews VP, McArthur JC (1993). Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 88: 112-118.
9. Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price RW (1991). Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778-785.
10. Klove H (1962). Clinical neuropsychology. In: The Medical Clinics of North America. Forster FM (ed). W.B. Saunders: New York, NY.
11. Le Tendre S, Ellis R, Heaton RK, Atkinson JH, McCutchan JA (1998). Change in CSF RNA level correlate with the effects of maximal antiretroviral therapy on HIV associated cognitive disorder. 12th World AIDS Conference, Geneva; 32198.
12. Matthews CG, Klove H (1964). Instruction manual for the adult neuropsychology test battery. University of Wisconsin Medical School: Madison, WI.
13. McArthur JC, Sacktor NC, Selnes O (1999). HIV-associated dementia. Sem Neurol (in press).
14. Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Muchedo AM, Van Esorp, WG Visscher B (1990). Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology 40: 197-203.
15. Power C, Selnes OA, Grim JA, McArthur JC (1995). The HIV Dementia Scale: Arapid screening test. J AIDS 8:273-278.
16. Reitan R (1958). Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8: 271-276.
17. Sacktor NC, McArthur JC (1997). Prospects for therapy of HIV-associated neurologic disease. J Neurovirol 3: 89-101.
18. Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN (1999). Combination antiretroviral therapy improves psychomotor speed performance in HIV+ homosexual men. Neurology 52: 1640-1647.
19. Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, Vischer B, McArthur JC (1991). Normative data for a brief neuropsychological screening battery. Perceptual Motor Skills 73: 539-550.
20. Smith A (1982). Symbol digit modalities test. Western Psychological Service: Los Angeles, CA.
21. Van Gorp WG, Miller EN, Satz P, Visscher B (1989). Neuropsychological performance in HIV-1-immunocompromised patients: a preliminary report. J Clin Exp Neuropsychol 11: 763-773.